We are live on
!
Find out more
TCM
Traynor Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
62.36%
This Fund
S&P 500
This Quarter
Est. Return
+1.18%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$120M
AUM Growth
+$15.6M
(+15%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
13.04%
Top 10 Holdings %
Top 10 Hldgs %
46.75%
Holding
154
New
30
Increased
62
Reduced
44
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$2.65M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$895K |
| 3 |
PGP
PIMCO Global StockPLUS & Income Fund
PGP
|
+$827K |
| 4 |
Biogen
BIIB
|
+$795K |
| 5 |
Pfizer
PFE
|
+$666K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$605K |
| 2 |
Manitowoc
MTW
|
+$406K |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$398K |
| 4 |
Advanced Micro Devices
AMD
|
+$346K |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.26% |
| 2 | Technology | 12.31% |
| 3 | Communication Services | 5.77% |
| 4 | Industrials | 3.81% |
| 5 | Energy | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBI
101
DELISTED
Chicago Bridge & Iron Nv
CBI
| $264K | 0.22% |
5,291
+351
| +7% | +$18.3K |
|
102
Alkermes
ALKS
$8.47B
| $263K | 0.22% |
4,100
-125
| -3% | -$7.65K |
|
103
Blackstone
BX
$109B
| $262K | 0.22% |
+6,537
| New | +$269K |
|
104
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $247K | 0.21% |
2,946
-3,069
| -51% | -$261K |
|
105
First Trust Consumer Staples AlphaDEX Fund
FXG
$228M
| $239K | 0.2% |
5,433
+772
| +17% | +$34.4K |
|
106
Amazon
AMZN
$2.98T
| $237K | 0.2% |
+10,920
| New | +$228K |
|
107
Boeing
BA
$188B
| $233K | 0.19% |
+1,685
| New | +$246K |
|
108
Oracle
ORCL
$417B
| $231K | 0.19% |
+5,749
| New | +$249K |
|
|
SGEN
109
DELISTED
Seagen Inc. Common Stock
SGEN
| $227K | 0.19% |
+4,695
| New | +$194K |
|
110
Fidelity MSCI Financials Index ETF
FNCL
$2.42B
| $226K | 0.19% |
+7,804
| New | +$228K |
|
111
NiSource
NI
$20.3B
| $226K | 0.19% |
12,646
| – | – |
|
112
iShares Select Dividend ETF
DVY
$23.5B
| $223K | 0.19% |
2,975
-619
| -17% | -$48.3K |
|
113
American Electric Power
AEP
$67.9B
| $222K | 0.19% |
4,200
| – | – |
|
114
Verizon
VZ
$189B
| $222K | 0.19% |
+4,769
| New | +$233K |
|
115
American Tower
AMT
$76B
| $218K | 0.18% |
2,338
-1,135
| -33% | -$107K |
|
116
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $211K | 0.18% |
2,116
-915
| -30% | -$93K |
|
117
Exelon
EXC
$46.7B
| $209K | 0.17% |
9,328
-464
| -5% | -$11.1K |
|
118
Invesco QQQ Trust
QQQ
$484B
| $209K | 0.17% |
+1,958
| New | +$213K |
|
119
BlackRock Enhanced International Dividend Trust
BGY
$524M
| $208K | 0.17% |
28,651
-2,140
| -7% | -$15.8K |
|
120
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $206K | 0.17% |
+1,002
| New | +$211K |
|
121
TherapeuticsMD
TXMD
$23.7M
| $206K | 0.17% |
526
-50
| -9% | -$17.6K |
|
122
Cisco
CSCO
$479B
| $203K | 0.17% |
+7,420
| New | +$213K |
|
123
PNC Financial Services
PNC
$102B
| $202K | 0.17% |
+2,121
| New | +$201K |
|
124
Vanguard Morningstar Value ETF
VTV
$191B
| $200K | 0.17% |
+2,400
| New | +$205K |
|
125
Nokia
NOK
$54.2B
| $189K | 0.16% |
27,730
-21,364
| -44% | -$156K |
|
Similar funds
SIG
ICM
CAG
ET
MMLI
MIAS
ORCP
TAL
Traynor Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Traynor Capital Management held 154 positions worth $120M, up 15% from $104M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Traynor Capital Management deployed $15.6M of net new capital in Q2 2015, opening 30 new positions and adding to 62 existing holdings. Its largest new stake was Biogen: 1,980 shares worth $799K.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $398K trimmed.
- Traynor Capital Management's largest Q2 2015 buy was Biogen: 1,980 shares worth $799K.
- Traynor Capital Management added most to Novo Nordisk in Q2 2015, an estimated $2.65M increase.
- Traynor Capital Management's biggest Q2 2015 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $398K.
- Traynor Capital Management fully exited Eli Lilly in Q2 2015, selling an estimated $605K.
- Traynor Capital Management's ten largest holdings make up 47% of its $120M portfolio in Q2 2015.
- Traynor Capital Management opened 30 new positions and closed 13 in Q2 2015.
- Traynor Capital Management's portfolio value rose 15% quarter-over-quarter to $120M.
Based on Traynor Capital Management's 13F filing for Q2 2015, filed 23 Feb 2016.